Fig 1.
PRISMA flow diagram of the included studies in the meta-analysis.
QTPmed: QT interval-prolonging medication; RCT: randomized control trial.
Fig 2.
Summary of risk of bias for included trials.
Fig 3.
Pooled events for MACE for Haloperidol versus control.
MACE: Major adverse cardiac events; RR: Risk ratio; CI: Confidence interval.
Table 1.
Subgroup analyses for mortality.
Table 2.
Sensitivity analyses for the outcome of mortality.